Metropolitan Life Insurance Company (MetLife)’s CONMED CNMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,677	Closed	-$134K	–	463
2024 Q1	$134K	Sell	1,677 -89	-5%	-$7.93K	0.01%	896
2023 Q4	$193K	Hold	1,766	–	–	0.01%	743
2023 Q3	$178K	Buy	1,766 +91	+5%	+$10.5K	0.01%	736
2023 Q2	$228K	Buy	1,675 +127	+8%	+$15.5K	0.01%	628
2023 Q1	$161K	Sell	1,548 -232	-13%	-$22.4K	0.01%	754
2022 Q4	$158K	Hold	1,780	–	–	0.01%	823
2022 Q3	$143K	Hold	1,780	–	–	0.01%	820
2022 Q2	$170K	Hold	1,780	–	–	0.01%	775
2022 Q1	$264K	Sell	1,780 -5,690	-76%	-$795K	0.01%	694
2021 Q4	$1.06M	Sell	7,470 -327	-4%	-$46.3K	0.01%	918
2021 Q3	$1.02M	Buy	7,797 +111	+1%	+$14.5K	0.01%	928
2021 Q2	$1.06M	Buy	7,686 +490	+7%	+$67.1K	0.01%	973
2021 Q1	$940K	Sell	7,196 -283	-4%	-$34.1K	0.01%	982
2020 Q4	$838K	Sell	7,479 -680	-8%	-$64.4K	0.01%	1006
2020 Q3	$642K	Hold	8,159	–	–	0.01%	1037
2020 Q2	$587K	Sell	8,159 -171	-2%	-$11.9K	0.01%	1081
2020 Q1	$477K	Sell	8,330 -340	-4%	-$31.4K	0.01%	1070
2019 Q4	$970K	Sell	8,670 -154	-2%	-$16.4K	0.02%	916
2019 Q3	$848K	Hold	8,824	–	–	0.01%	955
2019 Q2	$755K	Buy	8,824 +192	+2%	+$15.8K	0.01%	1060
2019 Q1	$718K	Sell	8,632 -196	-2%	-$14.2K	0.01%	1078
2018 Q4	$567K	Hold	8,828	–	–	0.01%	1115
2018 Q3	$699K	Hold	8,828	–	–	0.01%	1139
2018 Q2	$646K	Hold	8,828	–	–	0.01%	1149
2018 Q1	$559K	Buy	8,828 +242	+3%	+$14.4K	0.01%	1202
2017 Q4	$438K	Sell	8,586 -10,840	-56%	-$565K	0.01%	1375
2017 Q3	$1.02M	Hold	19,426	–	–	0.01%	1235
2017 Q2	$990K	Buy	19,426 +1,121	+6%	+$55.5K	0.01%	1251
2017 Q1	$813K	Sell	18,305 -2,354	-11%	-$101K	0.01%	1340
2016 Q4	$913K	Sell	20,659 -325	-2%	-$13.8K	0.01%	1344
2016 Q3	$841K	Sell	20,984 -686	-3%	-$29.1K	0.01%	1382
2016 Q2	$1.03M	Hold	21,670	–	–	0.01%	1239
2016 Q1	$909K	Buy	21,670 +3,050	+16%	+$120K	0.01%	1218
2015 Q4	$820K	Hold	18,620	–	–	0.01%	1293
2015 Q3	$889K	Sell	18,620 -547	-3%	-$30K	0.01%	1256
2015 Q2	$1.12M	Sell	19,167 -2,745	-13%	-$148K	0.01%	1219
2015 Q1	$1.11M	Hold	21,912	–	–	0.01%	1150
2014 Q4	$985K	Hold	21,912	–	–	0.01%	1323
2014 Q3	$807K	Hold	21,912	–	–	0.01%	1407
2014 Q2	$967K	Sell	21,912 -229	-1%	-$10.4K	0.01%	1373
2014 Q1	$962K	Sell	22,141 -939	-4%	-$41.8K	0.01%	1379
2013 Q4	$981K	Buy	23,080 +1,270	+6%	+$48.3K	0.01%	1338
2013 Q3	$741K	Sell	21,810 -1,476	-6%	-$48.2K	0.01%	1487
2013 Q2	$727K	Buy	+23,286	New	+$756K	0.01%	1443

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CNMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CONMED (CNMD) in Q2 2024, closing a stake of 1,677 shares — an estimated $134K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CNMD in Q2 2013 and held it in 44 quarters. The position peaked at $1.12M in Q2 2015. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,677 CONMED shares in Q2 2024, an estimated $134K.
Metropolitan Life Insurance Company (MetLife) first reported a position in CONMED in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s CONMED position peaked at $1.12M in Q2 2015.
290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.